GSK fires former US govt vaccine head Slaoui over harassment allegation

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 71 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

Glaxosmithkline said that Moncef Slaoui has been dismissed as chairman of Galvani Bioelectronics, which is majority owned by GSK.

FRANKFURT -GlaxoSmithKline has dismissed Moncef Slaoui, former U.S. government vaccine chief, as chairman of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed a GSK employee several years ago. GSK said the termination of Slaoui's contract at Galvani Bioelectronics was with immediate effect. Slaoui, the former chief adviser to the U.S.

GSK said an investigation of Slaoui’s conduct had substantiated allegations of harassment and inappropriate contact, adding that the probe was ongoing. The termination of Slaoui’s contract follows receipt of a letter containing the allegations of inappropriate conduct towards the employee of GSK, the company said in a statement. GSK said the allegations stemmed from when Slaoui was an employee of GSK.

"Dr. Slaoui’s behaviours represent an abuse of his leadership position and violate our company policies, our values, and our commitment to Trust – a commitment I know is shared by all of you," she said. Galvani is a bioelectronic medicines company set up in 2016 by GlaxoSmithKline and Verily, the life sciences unit of Google parent Alphabet.

Prior to his role at Galvani, Slaoui spent nearly 30 years at GlaxoSmithKline holding various leadership roles including Head of Pharmaceutical R&D and Chairman of its Vaccines division. Former U.S. President Donald Trump appointed Slaoui to lead his administration's effort to produce and distribute COVID-19 vaccines last year. He resigned from the post in January ahead of the incoming administration of President Joe Biden.Executive behaviour and treatment of employees has been under scrutiny over the past few years following the #MeToo social media movement prompting a string of high-profile boardroom departures.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GSK fires former US vaccine head Slaoui over harassment allegationGlaxosmithkline said that Moncef Slaoui has been dismissed as chairman of Galvani Bioelectronics, which is majority owned by GSK.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Vaxcyte asks chairman Slaoui to resign after GSK harassment allegationU.S. vaccine developer Vaxcyte Inc on Thursday asked board chairman Moncef Slaoui to step down, a day after GlaxoSmithKline dismissed him as an ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Former US govt vaccine chief exits two drug developers after GSK harassment claimU.S. vaccine developer Vaxcyte Inc on Thursday asked board chairman Moncef Slaoui to step down, a day after GlaxoSmithKline dismissed him as an ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US won't force NATO allies into 'us or them' choice on China: BlinkenThe United States will not force any NATO ally to choose sides between Washington and Beijing, US Secretary of State Antony Blinken said on ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

White House considering US$3 trillion for US economy: ReportsPresident Joe Biden's administration is considering spending US$3 trillion on infrastructure in the United States, split into two Bills that face ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »